Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ Factual Report
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Dendreon Corp To Close NJ Plant, Cut 600 Jobs-Reuters
Reuters reported that Dendreon Corp said it would close one of its three manufacturing plants and cut more than 600 full-time and contractor jobs over the next 12 months, with the aim of reducing annual costs by about $150 million a year. Dendreon had about 1,475 employees as of Feb. 23, 2012, according to a regulatory filing.
Latest Developments for Dendreon Corp
Latest Key Developments in Biotechnology
- Stemline Therapeutics Inc Announces Closing Of $60 Million Public Offering Of Common Stock
- Clavis Pharma ASA Appoints Interim Chairman and Acting CEO
- Oncolytics Biotech Inc Meets Primary Endpoint For First Stage Of U.S. Phase 2 Metastatic Melanoma Trial
- Progen Pharmaceuticals Ltd Announces Non-Renounceable Rights Issue Share Allotment
- Share this
- Link this
- Digg this
Follow Reuters